BioNTech SE
BNTX
$89.27
-$0.04-0.05%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -228.35% | -115.41% | 49.54% | -27.92% | -43.89% |
| Total Depreciation and Amortization | -248.79% | 197.47% | 7.77% | 8.33% | -69.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,852.50% | 121.26% | -398.40% | 103.24% | -141.07% |
| Change in Net Operating Assets | 64.13% | 201.41% | -76.06% | -281.46% | -474.99% |
| Cash from Operations | 172.95% | 229.95% | -90.51% | -138.51% | -153.91% |
| Capital Expenditure | -3.63% | 47.56% | 67.75% | 18.97% | 21.21% |
| Sale of Property, Plant, and Equipment | -6.39% | 928.02% | 163.59% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -575.37% | -1,263.36% | 73.95% | 159.29% | 125.50% |
| Cash from Investing | -590.61% | -592.47% | 71.87% | 152.45% | 122.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -160.27% | -45.57% | 41.92% | -76.92% | 40.65% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -113.92% | -54.80% | 38.76% | -71.51% | 43.97% |
| Foreign Exchange rate Adjustments | -88.76% | -894.06% | 393.96% | -329.52% | 109.63% |
| Miscellaneous Cash Flow Adjustments | 201.28% | -97.28% | -82.82% | 80.13% | -107.45% |
| Net Change in Cash | -2,022.83% | 75.03% | -93.63% | 115.26% | 107.42% |